Julphar’s Board of Directors names CFO Jerome CARLE as Acting General Manager
The Board of Directors of Julphar Gulf Pharmaceutical Industries – chaired by His Highness Sheikh Faisal Bin Saqr Al Qassimi – announced that it has appointed Julphar’s Chief Financial Officer Jerome Carle as Acting General Manager, which will be effective following the departure of current Chief Executive Officer, Dr Ayman Sahli on April 20th, 2017 and until a new CEO is appointed.
Commenting on the appointment of Jerome Carle as Acting General Manager, His Highness Sheikh Faisal Bin Saqr Al Qassimi, Chairman of Julphar, said: “The Board believes that Jerome is the right person to drive Julphar while we are looking for a new and highly qualified candidate to fill the CEO role, and we are grateful for Jerome’s readiness to endorse the role at this time. I want to thank Dr Ayman Sahli for his outstanding service to the company the past eight years, and I personally wish him well in the future."
Jerome Carle commented: “I would like to thank the Board of Directors for their trust. I am looking forward to working under their guidance. Together with the Executive team, I am confident that we will prepare a smooth transition until our new CEO is appointed and ensure that Julphar is in the right direction to reach our 2020 vision.”